Plea seeks all companies be allowed to sell it in domestic marketThe Delhi High Court on Monday asked the Centre and several pharmaceutical companies to respond to a petition seeking that all manufacturers of Remdesivir, used in COVID-19 treatment, be allowed to sell it in the domestic market. Also Read Plea seeks to regulate cost of HRCT tests for COVID-19A Bench of Chief Justice D.N. The plea claimed that only a handful of pharma companies are allowed to sell the medicine in the domestic market. It asked for direction to the remaining companies involved in manufacturing the drug for export to sell it in the domestic market. “It is pertinent to mention that the scarcity of Remdesivir is causing its extensive black marketing and the black marketers are charging prices up to ₹1,00,000 per vial, due to its non-availability.”

Source: The Hindu May 03, 2021 21:11 UTC